Renal transplant in sensitized patients: SIUT experience (TTS 2026) - Sep 17, 2026 - Abstract #P3.672; Pres time: Sep 21, 2026; 04:45 PM - 06:00 PM; Location: Hall 1-2; P3; "T and B cell FCXM was performed using polyclonal rabbit anti-human IgG/FITC, mean channel shift (MCS) >60 for T cells and >90 for B cells was considered positive...Desensitization included rituximab one month pre-transplant, 7–10 plasmapheresis sessions with IVIG 100 mg/kg after each session, one cycle of bortezomib and IVIG 2 g/kg one day before transplant... Immunological risk stratification using CDC, FCXM and SAB provides an effective framework for evaluating sensitized renal transplant recipients. Categorizing patients by degree of sensitization enables modification of desensitization therapy. Integrating multiple assays into pre-transplant evaluation may improve risk assessment and therapeutic decision-making."
Clinical • Transplant Rejection • Transplantation
|
|
Khawar Abbas1; Wajiha Musharraf1; Tahir Aziz2; Muhammad Mubarak3; Mirza Naqi Zafar4
|